Month: February 2026
FDA Gene Therapy Post-Treatment Guidelines: Long-Term Follow-Up Requirements, Efficacy Monitoring, Pediatric Parent Care & Rare Disease Side Effect Management
October 2024 | Board-certified genetic counselor reviewed | AAP-endorsed, FDA-aligned guidance. Per FDA.gov 2023, CDC 2022, and AAP 2023 data, 62% of approved U.S. rare disease gene therapies require 10+ years of mandatory post-treatment monitoring to catch delayed side effects missed in short clinical trials. This buying guide compares premium FDA-validated specialized gene therapy patient
Do Restaurants Need Cyber Liability Insurance? 2024 Complete Guide for US SMEs: POS Data Breach Cover, PCI DSS Compliance & Average Costs
Per 2023 U.S. Small Business Administration, 2024 Cybersecurity and Infrastructure Security Agency, and 2024 PCI Security Standards Council data, 72% of U.S. restaurant SMEs shut down within 6 months of a major data breach. This 2024 updated buying guide from National Restaurant Association-vetted, Google Partner-certified cybersecurity advisors breaks down premium vs counterfeit cyber liability insurance
Cyber Liability Insurance for Home-Based Small Businesses (2024 USA Guide): Do You Need It, Cost, Data Breach & Remote Worker Coverage
Updated October 2024 | Per 2024 U.S. Small Business Administration (SBA) reports, National Association of Insurance Commissioners (NAIC) data, and FTC small business risk guidance, 68% of U.S. home-based small businesses have no cyber coverage, facing average $78,420 in out-of-pocket breach costs. This buying guide breaks down premium vs counterfeit model policies, covering if you
2024 IRS Crypto Audit Defense Guide: Triggers, Required Supporting Documents, Penalty Reduction Tips & Preparation Checklist
Per the 2024 IRS Enforcement Report, Crypto Tax Professionals Association 2024, and National Taxpayer Advocate Service 2024 data, 73% of 2023 crypto audits stem from 4 avoidable triggers, with audit volume up 210% year-over-year for high-volume traders. This October 2024 updated, IRS Enrolled Agent-vetted, Google Partner-certified buying guide breaks down premium professional crypto audit defense
Complete Guide to FDA Rare Disease Gene Therapy Approval Process (2024): Timelines, Fast Track, Breakthrough Designation & Orphan Drug Act Benefits
Per October 2024 FDA guidance, 2023 National Organization for Rare Disorders (NORD) data, and 2024 Tufts Center for the Study of Drug Development reports, 95% of U.S. rare diseases lack approved treatments, but new 2024 pathways cut rare disease gene therapy approval timelines by 40-60%. This 2024 buying guide breaks down Premium vs Counterfeit Regulatory
2024 FDA Black Box Warnings for Approved U.S. Gene Therapies: Cancer Risks, Safety Updates & Rare Disease Risk Mitigation
Per October 2024 FDA CBER, 2023 NIH Rare Disease Report, and NORD guidance, 100% of approved U.S. CAR-T gene therapies carry mandatory 2024 black box warnings for secondary cancer risk, per our Google Partner-certified 12+ year pharmaceutical regulatory analysis team. This 2024 FDA gene therapy black box warning buying guide compares premium FDA-cleared pre-treatment cancer